Precision BioSciences, Inc. (DTIL) — Analyst outlook / Analyst consensus target is. Based on 12 analyst ratings, the consensus is bullish — 9 Buy, 3 Hold.
The consensus price target is $19.00, representing an upside of 162.8% from the current price $7.23.
Analysts estimate Earnings Per Share (EPS) of $0.07 and revenue of $0.07B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $1.05 vs est $0.07 (beat +1455.6%). 2025: actual $-3.63 vs est $-6.14 (beat +40.8%). Analyst accuracy: 19%.
DTIL Stock — 12-Month Price Forecast
$19.00
▲ +162.79% Upside
Average Price Target
Based on 12 Wall Street analysts offering 12-month price targets for Precision BioSciences, Inc., the price target is $19.00.
The average price target represents a +162.79% change from the last price of $7.23.
DTIL Analyst Ratings
Buy
Based on 12 analysts giving stock ratings to Precision BioSciences, Inc. in the past 3 months
EPS Estimates — DTIL
19%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024
Actual $1.05
vs Est $0.07
▲ 93.6% off
2025
Actual –$3.63
vs Est –$6.14
▲ 69.0% off
Profitability Outlook
Company has mixed profitability — some years profitable, some at a loss. Analysts expect the company to turn profitable.
Revenue Estimates — DTIL
61%
Analyst Accuracy
Fair
2 years compared
Actual vs Estimate
2024
Actual $0.069B
vs Est $0.072B
▼ 5.2% off
2025
Actual $0.034B
vs Est $0.009B
▲ 73.3% off
Revenue Trend
Revenue has declined over the period shown. Analysts forecast significant revenue growth ahead.
